Parametric Portfolio Associates’s Cumberland Pharmaceuticals CPIX Stock Holding History

Parametric Portfolio Associates’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,466	Closed	-$49K	–	3690
2021 Q4	$49K	Sell	10,466 -2,410	-19%	-$8.22K	﹤0.01%	3599
2021 Q3	$35K	Sell	12,876 -420	-3%	-$1.25K	﹤0.01%	3589
2021 Q2	$38K	Sell	13,296 -2,322	-15%	-$6.83K	﹤0.01%	3545
2021 Q1	$47K	Sell	15,618 -993	-6%	-$3.23K	﹤0.01%	4025
2020 Q4	$49K	Buy	16,611 +1,617	+11%	+$4.89K	﹤0.01%	3948
2020 Q3	$48K	Buy	+14,994	New	+$49.3K	﹤0.01%	3870
2019 Q4	–	Sell	-13,556	Closed	-$80K	–	3966
2019 Q3	$80K	Buy	+13,556	New	+$75.4K	﹤0.01%	3867
2014 Q1	–	Sell	-10,161	Closed	-$52K	–	3830
2013 Q4	$52K	Buy	+10,161	New	+$49.6K	﹤0.01%	3775

Other funds holding CPIX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BAM

Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametric Portfolio Associates's CPIX Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2022, closing a stake of 10,466 shares — an estimated $49K sold.

Parametric Portfolio Associates first reported a position in CPIX in Q4 2013 and held it in 8 quarters. The position peaked at $80K in Q3 2019. 26 funds tracked by Wall St. Rank hold CPIX as of Q1 2022.

Parametric Portfolio Associates reported no remaining Cumberland Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Parametric Portfolio Associates sold 10,466 Cumberland Pharmaceuticals shares in Q1 2022, an estimated $49K.
Parametric Portfolio Associates first reported a position in Cumberland Pharmaceuticals in Q4 2013 and held it in 8 quarters.
Parametric Portfolio Associates's Cumberland Pharmaceuticals position peaked at $80K in Q3 2019.
26 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.